Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

IL6 Signaling in Peripheral Blood T Cells Predicts Clinical Outcome in Breast Cancer.

Wang L, Miyahira AK, Simons DL, Lu X, Chang AY, Wang C, Suni MA, Maino VC, Dirbas FM, Yim J, Waisman J, Lee PP.

Cancer Res. 2017 Mar 1;77(5):1119-1126. doi: 10.1158/0008-5472.CAN-16-1373. Epub 2016 Nov 22.

2.

Probability state modeling of memory CD8⁺ T-cell differentiation.

Inokuma MS, Maino VC, Bagwell CB.

J Immunol Methods. 2013 Nov 29;397(1-2):8-17. doi: 10.1016/j.jim.2013.08.003. Epub 2013 Aug 14.

3.

Clinical implications of detecting low-abundance RNAs by flow cytometry.

Maino VC, Park E.

Expert Rev Mol Diagn. 2013 Jul;13(6):511-3. doi: 10.1586/14737159.2013.811904. No abstract available.

PMID:
23895119
4.

VTX-2337 is a novel TLR8 agonist that activates NK cells and augments ADCC.

Lu H, Dietsch GN, Matthews MA, Yang Y, Ghanekar S, Inokuma M, Suni M, Maino VC, Henderson KE, Howbert JJ, Disis ML, Hershberg RM.

Clin Cancer Res. 2012 Jan 15;18(2):499-509. doi: 10.1158/1078-0432.CCR-11-1625. Epub 2011 Nov 29.

5.

Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers.

Butterfield LH, Palucka AK, Britten CM, Dhodapkar MV, Håkansson L, Janetzki S, Kawakami Y, Kleen TO, Lee PP, Maccalli C, Maecker HT, Maino VC, Maio M, Malyguine A, Masucci G, Pawelec G, Potter DM, Rivoltini L, Salazar LG, Schendel DJ, Slingluff CL Jr, Song W, Stroncek DF, Tahara H, Thurin M, Trinchieri G, van Der Burg SH, Whiteside TL, Wigginton JM, Marincola F, Khleif S, Fox BA, Disis ML.

Clin Cancer Res. 2011 May 15;17(10):3064-76. doi: 10.1158/1078-0432.CCR-10-2234. Epub 2011 May 10. Review.

6.

Flow cytometric analysis of cell signaling proteins.

Suni MA, Maino VC.

Methods Mol Biol. 2011;717:155-69. doi: 10.1007/978-1-61779-024-9_9.

PMID:
21370030
7.

Quality assurance of intracellular cytokine staining assays: analysis of multiple rounds of proficiency testing.

Jaimes MC, Maecker HT, Yan M, Maino VC, Hanley MB, Greer A, Darden JM, D'Souza MP.

J Immunol Methods. 2011 Jan 5;363(2):143-57. doi: 10.1016/j.jim.2010.08.004. Epub 2010 Aug 19.

8.

Cross-reactive monoclonal antibodies to multiple HIV-1 subtype and SIVcpz envelope glycoproteins.

Gao F, Scearce RM, Alam SM, Hora B, Xia S, Hohm JE, Parks RJ, Ogburn DF, Tomaras GD, Park E, Lomas WE, Maino VC, Fiscus SA, Cohen MS, Moody MA, Hahn BH, Korber BT, Liao HX, Haynes BF.

Virology. 2009 Nov 10;394(1):91-8. doi: 10.1016/j.virol.2009.07.041. Epub 2009 Sep 9.

9.

Retention of viability, cytotoxicity, and response to IL-2, IL-15, or IFN-alpha by human NK cells after CD107a degranulation.

Tomescu C, Chehimi J, Maino VC, Montaner LJ.

J Leukoc Biol. 2009 May;85(5):871-6. doi: 10.1189/jlb.1008635. Epub 2009 Feb 23.

10.

Standardization and optimization of multiparameter intracellular cytokine staining.

Nomura L, Maino VC, Maecker HT.

Cytometry A. 2008 Nov;73(11):984-91. doi: 10.1002/cyto.a.20602.

11.

Precision and linearity targets for validation of an IFNgamma ELISPOT, cytokine flow cytometry, and tetramer assay using CMV peptides.

Maecker HT, Hassler J, Payne JK, Summers A, Comatas K, Ghanayem M, Morse MA, Clay TM, Lyerly HK, Bhatia S, Ghanekar SA, Maino VC, Delarosa C, Disis ML.

BMC Immunol. 2008 Mar 17;9:9. doi: 10.1186/1471-2172-9-9.

12.

Progressive CD4+ central memory T cell decline results in CD4+ effector memory insufficiency and overt disease in chronic SIV infection.

Okoye A, Meier-Schellersheim M, Brenchley JM, Hagen SI, Walker JM, Rohankhedkar M, Lum R, Edgar JB, Planer SL, Legasse A, Sylwester AW, Piatak M Jr, Lifson JD, Maino VC, Sodora DL, Douek DC, Axthelm MK, Grossman Z, Picker LJ.

J Exp Med. 2007 Sep 3;204(9):2171-85. Epub 2007 Aug 27. Erratum in: J Exp Med. 2007 Oct;204(10):2493.

13.

Functional T cell responses to tumor antigens in breast cancer patients have a distinct phenotype and cytokine signature.

Inokuma M, dela Rosa C, Schmitt C, Haaland P, Siebert J, Petry D, Tang M, Suni MA, Ghanekar SA, Gladding D, Dunne JF, Maino VC, Disis ML, Maecker HT.

J Immunol. 2007 Aug 15;179(4):2627-33.

14.
15.

Phenotype and in vitro function of mature MDDC generated from cryopreserved PBMC of cancer patients are equivalent to those from healthy donors.

Ghanekar SA, Bhatia S, Ruitenberg JJ, DeLa Rosa C, Disis ML, Maino VC, Maecker HT, Waters CA.

J Immune Based Ther Vaccines. 2007 May 3;5:7.

16.

Early and delayed benefits of HIV-1 suppression: timeline of recovery of innate immunity effector cells.

Azzoni L, Chehimi J, Zhou L, Foulkes AS, June R, Maino VC, Landay A, Rinaldo C, Jacobson LP, Montaner LJ.

AIDS. 2007 Jan 30;21(3):293-305.

PMID:
17255736
17.
18.

IL-15 induces CD4 effector memory T cell production and tissue emigration in nonhuman primates.

Picker LJ, Reed-Inderbitzin EF, Hagen SI, Edgar JB, Hansen SG, Legasse A, Planer S, Piatak M Jr, Lifson JD, Maino VC, Axthelm MK, Villinger F.

J Clin Invest. 2006 Jun;116(6):1514-24. Epub 2006 May 11.

19.

Maximizing the retention of antigen specific lymphocyte function after cryopreservation.

Disis ML, dela Rosa C, Goodell V, Kuan LY, Chang JC, Kuus-Reichel K, Clay TM, Kim Lyerly H, Bhatia S, Ghanekar SA, Maino VC, Maecker HT.

J Immunol Methods. 2006 Jan 20;308(1-2):13-8. Epub 2005 Oct 21.

PMID:
16337957
20.

Impact of cryopreservation on tetramer, cytokine flow cytometry, and ELISPOT.

Maecker HT, Moon J, Bhatia S, Ghanekar SA, Maino VC, Payne JK, Kuus-Reichel K, Chang JC, Summers A, Clay TM, Morse MA, Lyerly HK, DeLaRosa C, Ankerst DP, Disis ML.

BMC Immunol. 2005 Jul 18;6:17.

21.

Standardization of cytokine flow cytometry assays.

Maecker HT, Rinfret A, D'Souza P, Darden J, Roig E, Landry C, Hayes P, Birungi J, Anzala O, Garcia M, Harari A, Frank I, Baydo R, Baker M, Holbrook J, Ottinger J, Lamoreaux L, Epling CL, Sinclair E, Suni MA, Punt K, Calarota S, El-Bahi S, Alter G, Maila H, Kuta E, Cox J, Gray C, Altfeld M, Nougarede N, Boyer J, Tussey L, Tobery T, Bredt B, Roederer M, Koup R, Maino VC, Weinhold K, Pantaleo G, Gilmour J, Horton H, Sekaly RP.

BMC Immunol. 2005 Jun 24;6:13.

22.

Ex vivo analysis of T-cell function.

Suni MA, Maino VC, Maecker HT.

Curr Opin Immunol. 2005 Aug;17(4):434-40. Review.

PMID:
15950444
23.

Multicolor flow cytometric analysis in SIV-infected rhesus macaque.

Walker JM, Maecker HT, Maino VC, Picker LJ.

Methods Cell Biol. 2004;75:535-57. No abstract available.

PMID:
15603441
24.

Insufficient production and tissue delivery of CD4+ memory T cells in rapidly progressive simian immunodeficiency virus infection.

Picker LJ, Hagen SI, Lum R, Reed-Inderbitzin EF, Daly LM, Sylwester AW, Walker JM, Siess DC, Piatak M Jr, Wang C, Allison DB, Maino VC, Lifson JD, Kodama T, Axthelm MK.

J Exp Med. 2004 Nov 15;200(10):1299-314.

25.

Analyzing T-cell responses to cytomegalovirus by cytokine flow cytometry.

Maecker HT, Maino VC.

Hum Immunol. 2004 May;65(5):493-9. Review.

PMID:
15172449
26.
27.

T cell immunity to HIV: defining parameters of protection.

Maecker HT, Maino VC.

Curr HIV Res. 2003 Apr;1(2):249-59. Review.

PMID:
15043207
28.

Presence of human immunodeficiency virus-1-specific CD4 and CD8 cellular immune responses in children with full or partial virus suppression.

Papasavvas E, Sandberg JK, Rutstein R, Moore EC, Mackiewicz A, Thiel B, Pistilli M, June RR, Jordan KA, Gross R, Maino VC, Nixon DF, Montaner LJ.

J Infect Dis. 2003 Sep 15;188(6):873-82. Epub 2003 Sep 4. Erratum in: J Infect Dis. 2003 Dec 15;188(12):1961.

PMID:
12964119
29.

Performance of plate-based cytokine flow cytometry with automated data analysis.

Suni MA, Dunn HS, Orr PL, de Laat R, Sinclair E, Ghanekar SA, Bredt BM, Dunne JF, Maino VC, Maecker HT.

BMC Immunol. 2003 Sep 2;4:9. Epub 2003 Sep 2.

30.

Direct ex vivo analysis of human CD4(+) memory T cell activation requirements at the single clonotype level.

Bitmansour AD, Douek DC, Maino VC, Picker LJ.

J Immunol. 2002 Aug 1;169(3):1207-18.

31.

BD Biosciences contributions in CD4 counting and immune status for HIV/AIDS.

Hoffman RA, Maino VC, Recktenwald DJ, Webster HK.

Cytometry. 2002 Apr 15;50(2):129-32. Review.

32.

Immunologic monitoring of cancer vaccine therapy: results of a workshop sponsored by the Society for Biological Therapy.

Keilholz U, Weber J, Finke JH, Gabrilovich DI, Kast WM, Disis ML, Kirkwood JM, Scheibenbogen C, Schlom J, Maino VC, Lyerly HK, Lee PP, Storkus W, Marincola F, Worobec A, Atkins MB.

J Immunother. 2002 Mar-Apr;25(2):97-138. Review.

PMID:
12074049
33.

Development and homeostasis of T cell memory in rhesus macaque.

Pitcher CJ, Hagen SI, Walker JM, Lum R, Mitchell BL, Maino VC, Axthelm MK, Picker LJ.

J Immunol. 2002 Jan 1;168(1):29-43.

34.

Decreased expression of IL-2 in central and effector CD4 memory cells during progression to AIDS in rhesus macaques.

Koopman G, Niphuis H, Newman W, Kishimoto TK, Maino VC, Heeney JL.

AIDS. 2001 Dec 7;15(18):2359-69.

PMID:
11740186
35.

Decreased HIV-specific CD4 T cell proliferation in long-term HIV-infected individuals on antiretroviral therapy.

Ghanekar SA, Stranford SA, Ong JC, Walker JM, Maino VC, Levy JA.

AIDS. 2001 Sep 28;15(14):1885-7.

PMID:
11579254
36.

CD4(+)CD8(dim) T lymphocytes exhibit enhanced cytokine expression, proliferation and cytotoxic activity in response to HCMV and HIV-1 antigens.

Suni MA, Ghanekar SA, Houck DW, Maecker HT, Wormsley SB, Picker LJ, Moss RB, Maino VC.

Eur J Immunol. 2001 Aug;31(8):2512-20.

37.

Use of overlapping peptide mixtures as antigens for cytokine flow cytometry.

Maecker HT, Dunn HS, Suni MA, Khatamzas E, Pitcher CJ, Bunde T, Persaud N, Trigona W, Fu TM, Sinclair E, Bredt BM, McCune JM, Maino VC, Kern F, Picker LJ.

J Immunol Methods. 2001 Sep 1;255(1-2):27-40.

PMID:
11470284
38.

Clonotypic structure of the human CD4+ memory T cell response to cytomegalovirus.

Bitmansour AD, Waldrop SL, Pitcher CJ, Khatamzas E, Kern F, Maino VC, Picker LJ.

J Immunol. 2001 Aug 1;167(3):1151-63.

39.

Factors affecting the efficiency of CD8+ T cell cross-priming with exogenous antigens.

Maecker HT, Ghanekar SA, Suni MA, He XS, Picker LJ, Maino VC.

J Immunol. 2001 Jun 15;166(12):7268-75.

40.
41.

Direct functional analysis of epitope-specific CD8+ T cells in peripheral blood.

He XS, Rehermann B, Boisvert J, Mumm J, Maecker HT, Roederer M, Wright TL, Maino VC, Davis MM, Greenberg HB.

Viral Immunol. 2001;14(1):59-69.

PMID:
11270597
42.

Immunofluorescence analysis of T-cell responses in health and disease.

Maecker HT, Maino VC, Picker LJ.

J Clin Immunol. 2000 Nov;20(6):391-9. Review.

PMID:
11202228
43.

Enhancement of HIV Type 1 Antigen-Specific CD4+ T Cell Memory in Subjects with Chronic HIV Type 1 Infection Receiving an HIV Type 1 Immunogen.

Maino VC, Suni MA, Wormsley SB, Carlo DJ, Wallace MR, Moss RB.

AIDS Res Hum Retroviruses. 2000 Dec;16(18):2065-2066. No abstract available.

PMID:
11153091
44.
45.

The CD4(+) T cell response to HIV-1.

Picker LJ, Maino VC.

Curr Opin Immunol. 2000 Aug;12(4):381-6. Review.

PMID:
10899031
46.

Enhancement of HIV type 1 antigen-specific CD4+ T cell memory in subjects with chronic HIV type 1 infection receiving an HIV type 1 immunogen.

Maino VC, Suni MA, Wormsley SB, Carlo DJ, Wallace MR, Moss RB.

AIDS Res Hum Retroviruses. 2000 Apr 10;16(6):539-47. Erratum in: AIDS Res Hum Retroviruses 2000 Dec 10;16(18):2065-6.

PMID:
10777144
47.

Flow cytometric measurement of intracellular cytokines detects immune responses in MUC1 immunotherapy.

Karanikas V, Lodding J, Maino VC, McKenzie IF.

Clin Cancer Res. 2000 Mar;6(3):829-37.

48.
49.

HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression.

Pitcher CJ, Quittner C, Peterson DM, Connors M, Koup RA, Maino VC, Picker LJ.

Nat Med. 1999 May;5(5):518-25.

PMID:
10229228
50.

A 15-year follow-up of AJCC stage III malignant melanoma patients treated postsurgically with Newcastle disease virus (NDV) oncolysate and determination of alterations in the CD8 T cell repertoire.

Batliwalla FM, Bateman BA, Serrano D, Murray D, Macphail S, Maino VC, Ansel JC, Gregersen PK, Armstrong CA.

Mol Med. 1998 Dec;4(12):783-94.

Supplemental Content

Loading ...
Support Center